Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Title||Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)|
|Recruitment||Active, not recruiting|
|Sponsors||Merck Sharp & Dohme Corp.|
|Age Groups:||adult | senior|
|Covered Countries||USA | ITA | ESP | CAN | AUT|